We are live on
!
Find out more
Immunic
IMUX
IMUX
62 hedge funds and large institutions have $95M invested in Immunic in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
186% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 7
25% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 16
17% more capital invested
Capital invested by funds: $81.3M → $95M (+$13.7M)
7% more funds holding
Funds holding: 58 → 62 (+4)
0.01% more ownership
Funds ownership: 0.07% → 0.08% (+0.01%)
77% less call options, than puts
Call options by funds: $754K | Put options by funds: $3.29M
Holders
62
Holders Change
+4
Holders Change %
+6.9%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
20
Reduced
7
Closed
16
Calls
$754K
Puts
$3.29M
Net Calls
-$2.53M
Net Calls Change
-$1.82M
Top Buyers
| 1 |
BlackRock
New York
|
+$7.44M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$6.33M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.93M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.47M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$917K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.7M |
| 2 |
Millennium Management
New York
|
-$2.33M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.12M |
| 4 |
Goldman Sachs
New York
|
-$936K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$416K |
